Lung Function in Very Low Birth Weight Infants After Pharmacological and Surgical Treatment of Patent Ductus Arteriosus - a Retrospective Analysis

Overview

Journal BMC Pediatr

Publisher Biomed Central

Specialty Pediatrics

Date 2017 Jan 7

PMID 28056907

Citations 3

Authors

Payman Barikbin

Hannes Sallmon

Silke Wilitzki

Joachim Photiadis

Christoph Buhrer

Petra Koehne

Gerd Schmalisch

Affiliations

Soon will be listed here.

Abstract

Background: The indications and strategies for treatment of patent ductus arteriosus (PDA) are controversial, and the safety and long-term benefits of surgical PDA closure remain uncertain. The aim of this study was to compare the lung function of very low birth weight (VLBW) infants after successful PDA treatment with a cyclooxygenase inhibitor or secondary surgical ligation.

Methods: A total of 114 VLBW infants (birth weight < 1500 g), including 94 infants (82%) with a birth weight < 1000 g, who received treatment for hemodynamically significant PDA (hsPDA), were examined at a median postmenstrual age of 48 weeks. All infants were initially given pharmacological treatment, and 40 infants (35%) required PDA ligation. Lung function testing (LFT) included tidal breathing measurements, measurement of respiratory mechanics assessed by the occlusion test, whole-body plethysmography, SF multiple breath washout, forced expiratory flow (V'max) by the rapid thoracoabdominal compression technique, exhaled NO (FeNO), and arterialized capillary blood gas analysis.

Results: On the day of the LFT, the 2 groups had similar postconceptional age and body weight. However, the PDA ligation group was more immature at birth (p < 0.001) and had reduced respiratory compliance (p < 0.001), lower V'max (p = 0.006), increased airway resistance (R) (p < 0.001), and impaired blood gases (p < 0.001). Multivariate analysis showed that PDA surgery was an independent risk factor for increased R.

Conclusion: PDA ligation after failed pharmacological treatment is associated with impaired lung function as compared to successful pharmacological closure in infants at a postmenstrual age of 48 weeks. However, only Raw was independently affected by PDA ligation, while all other differences were merely explained by patient characteristics.

Citing Articles

Differences in Comorbidities and Clinical Burden of Severe Bronchopulmonary Dysplasia Based on Disease Severity.

Kim H, Jung Y, Kim B, Kim S, Choi C Front Pediatr. 2021; 9:664033.

PMID: 34277516 PMC: 8283123. DOI: 10.3389/fped.2021.664033.

Respiratory Trajectory after Invasive Interventions for Patent Ductus Arteriosus of Preterm Infants.

Wei Y, Chen Y, Lin Y, Kan C, Hsieh M, Lin Y Children (Basel). 2021; 8(5).

PMID: 34063345 PMC: 8156843. DOI: 10.3390/children8050398.

Further Experience with Oral Paracetamol as a Rescue Therapy for Patent Ductus Arteriosus in Preterm Infants.

Sallmon H, Koehne P Pediatr Cardiol. 2017; 39(2):411-412.

PMID: 29218362 DOI: 10.1007/s00246-017-1791-6.

References

El-Khuffash A, Jain A, McNamara P . Ligation of the patent ductus arteriosus in preterm infants: understanding the physiology. J Pediatr. 2013; 162(6):1100-6. DOI: 10.1016/j.jpeds.2012.12.094. View

Ohlsson A, Walia R, Shah S . Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst Rev. 2015; (2):CD003481. DOI: 10.1002/14651858.CD003481.pub6. View

Hoo A, Dezateux C, Hanrahan J, Cole T, Tepper R, Stocks J . Sex-specific prediction equations for Vmax(FRC) in infancy: a multicenter collaborative study. Am J Respir Crit Care Med. 2002; 165(8):1084-92. DOI: 10.1164/ajrccm.165.8.2103035. View

Sallmon H, Koehne P, Hansmann G . Recent Advances in the Treatment of Preterm Newborn Infants with Patent Ductus Arteriosus. Clin Perinatol. 2016; 43(1):113-29. DOI: 10.1016/j.clp.2015.11.008. View

Szymankiewicz M, Hodgman J, Siassi B, Gadzinowski J . Mechanics of breathing after surgical ligation of patent ductus arteriosus in newborns with respiratory distress syndrome. Biol Neonate. 2003; 85(1):32-6. DOI: 10.1159/000074955. View

Schmalisch G, Wilitzki S, Roehr C, Proquitte H, Buhrer C . Differential effects of immaturity and neonatal lung disease on the lung function of very low birth weight infants at 48-52 postconceptional weeks. Pediatr Pulmonol. 2013; 48(12):1214-23. DOI: 10.1002/ppul.22770. View

Alfaleh K, Alluwaimi E, AlOsaimi A, Alrajebah S, Alotaibi B, AlRasheed F . A prospective study of maternal preference for indomethacin prophylaxis versus symptomatic treatment of a patent ductus arteriosus in preterm infants. BMC Pediatr. 2015; 15:47. PMC: 4414008. DOI: 10.1186/s12887-015-0353-4. View

Kabra N, Schmidt B, Roberts R, Doyle L, Papile L, Fanaroff A . Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr. 2007; 150(3):229-34, 234.e1. DOI: 10.1016/j.jpeds.2006.11.039. View

Latzin P, Roth S, Thamrin C, Hutten G, Pramana I, Kuehni C . Lung volume, breathing pattern and ventilation inhomogeneity in preterm and term infants. PLoS One. 2009; 4(2):e4635. PMC: 2645689. DOI: 10.1371/journal.pone.0004635. View

10.

Naulty C, Horn S, Conry J, Avery G . Improved lung compliance after ligation of patent ductus arteriosus in hyaline membrane disease. J Pediatr. 1978; 93(4):682-4. DOI: 10.1016/s0022-3476(78)80917-2. View

11.

Gerhardt T, Bancalari E . Lung compliance in newborns with patent ductus arteriosus before and after surgical ligation. Biol Neonate. 1980; 38(1-2):96-105. DOI: 10.1159/000241348. View

12.

Heuchan A, Clyman R . Managing the patent ductus arteriosus: current treatment options. Arch Dis Child Fetal Neonatal Ed. 2014; 99(5):F431-6. DOI: 10.1136/archdischild-2014-306176. View

13.

Saarinen A, Rihkanen H, Malmberg L, Pekkanen L, Sovijarvi A . Disturbances in airflow dynamics and tracheal sounds during forced and quiet breathing in subjects with unilateral vocal fold paralysis. Clin Physiol. 2001; 21(6):712-7. DOI: 10.1046/j.1365-2281.2001.00375.x. View

14.

Chen H, Yang R, Lee W, Lee P, Hsu J, Wu J . Lung function in very preterm infants with patent ductus arteriosus under conservative management: an observational study. BMC Pediatr. 2015; 15:167. PMC: 4620001. DOI: 10.1186/s12887-015-0480-y. View

15.

Strychowsky J, Rukholm G, Gupta M, Reid D . Unilateral vocal fold paralysis after congenital cardiothoracic surgery: a meta-analysis. Pediatrics. 2014; 133(6):e1708-23. DOI: 10.1542/peds.2013-3939. View

16.

Kort E . Patent Ductus Arteriosus in the Preterm Infant: An Update on Morbidity and Mortality. Curr Pediatr Rev. 2016; 12(2):98-105. DOI: 10.2174/157339631202160506001621. View

17.

Weber S, Weiss K, Buhrer C, Hansmann G, Koehne P, Sallmon H . Natural History of Patent Ductus Arteriosus in Very Low Birth Weight Infants after Discharge. J Pediatr. 2015; 167(5):1149-51. DOI: 10.1016/j.jpeds.2015.06.032. View

18.

Hoo A, Dezateux C, Henschen M, Costeloe K, Stocks J . Development of airway function in infancy after preterm delivery. J Pediatr. 2002; 141(5):652-8. DOI: 10.1067/mpd.2002.128114. View

19.

Sallmon H, Weber S, Huning B, Stein A, Horn P, Metze B . Thrombocytopenia in the first 24 hours after birth and incidence of patent ductus arteriosus. Pediatrics. 2012; 130(3):e623-30. DOI: 10.1542/peds.2012-0499. View

20.

Sly P, Tepper R, Henschen M, Gappa M, Stocks J . Tidal forced expirations. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/American Thoracic Society. Eur Respir J. 2000; 16(4):741-8. DOI: 10.1034/j.1399-3003.2000.16d29.x. View